Welcome to Paid Research Studies




  • Conditions:   Arteritis, Giant Cell;   Blindness and Low Vision
    Intervention:   Drug: treatment
    Sponsor:   Centre Hospitalier Universitaire de Nice
    Not yet recruiting

  • Condition:   Blindness
    Intervention:   Device: BrainPort V200 Device
    Sponsor:   University of Pittsburgh
    Recruiting

  • Condition:   Blindness
    Intervention:   Procedure: Minicraniotomy
    Sponsors:   Universidad Miguel Hernandez de Elche;   Hospital IMED Elche
    Recruiting

  • Conditions:   Color Blindness, Red;   Reaction Time
    Intervention:   Diagnostic Test: Anomaloscope (colour vision test)
    Sponsors:   Aalen University;   Karlsruhe Institute of Technology (KIT), Karlsruhe/FRG
    Not yet recruiting

  • Conditions:   Blindness, Acquired;   Blindness Congenital
    Interventions:   Device: active tDCS;   Device: sham tDCS;   Other: Dynamic proprioceptive exercises;   Other: static proprioceptive exercises
    Sponsors:   Salgado Institute of Integral Health;   University of Nove de Julho
    Not yet recruiting

  • Condition:   Corneal Blindness
    Intervention:   Device: KeraKlear Non-Penetrating Keratoprosthesis
    Sponsors:   KeraMed, Inc.;   National Eye Institute (NEI);   ClinReg Consulting Services, Inc.
    Recruiting

  • Conditions:   Visual Deficiency;   Congenital Blindness;   Acquired Blindness
    Intervention:   Diagnostic Test: VISIODOL® (Diagnostic tool)
    Sponsor:   University Hospital, Clermont-Ferrand
    Recruiting

  • Condition:   Blindness,Visual Impairment, Refractive Error, Cataract, High Myopia, Aging
    Intervention:   Device: spectacles
    Sponsors:   Shanghai Eye Disease Prevention and Treatment Center;   Brien Holden Vision
    Recruiting

  • Conditions:   Eye Diseases Hereditary;   Retinal Disease;   Achromatopsia;   Bardet-Biedl Syndrome;   Bassen-Kornzweig Syndrome;   Batten Disease;   Best Disease;   Choroidal Dystrophy;   Choroideremia;   Cone Dystrophy;   Cone-Rod Dystrophy;   Congenital Stationary Night Blindness;   Enhanced S-Cone Syndrome;   Fundus Albipunctatus;   Goldmann-Favre Syndrome;   Gyrate Atrophy;   Juvenile Macular Degeneration;   Kearns-Sayre Syndrome;   Leber Congenital Amaurosis;   Refsum Syndrome;   Retinitis Pigmentosa;   Retinitis Punctata Albescens;   Retinoschisis;   Rod-Cone Dystrophy;   Rod Dystrophy;   Rod Monochromacy;   Stargardt Disease;   Usher Syndrome
    Intervention:  
    Sponsor:   Foundation Fighting Blindness
    Recruiting

  • Condition:   Dry Age-related Macular Degeneration
    Intervention:   Device: PRIMA
    Sponsors:   Pixium Vision SA;   Pixium Vision LLC acts as sponosor in the US on behalf of Pixium Vision SA
    Recruiting

  • Conditions:   Hemianopia;   Hemianopsia;   Peripheral Visual Field Defect;   Blindness;   Retinitis Pigmentosa;   Glaucoma
    Intervention:   Device: Collision warning device
    Sponsor:   Massachusetts Eye and Ear Infirmary
    Recruiting

  • Condition:   Leber's Congenital Amaurosis
    Interventions:   Drug: SAR439483;   Drug: SAR439483 Diluent Solution;   Drug: Prednisone;   Drug: Triamcinalone Acetonide;   Drug: 1% Prednisolone;   Drug: Trimethoprim/polymyxin B
    Sponsor:   Sanofi
    Not yet recruiting

  • Condition:   Leber Congenital Amaurosis
    Intervention:  
    Sponsor:   MeiraGTx UK II Ltd
    Recruiting

  • Conditions:   Vitamin A Deficiency;   Iron Deficiency;   Zinc Deficiency
    Interventions:   Other: Multiple biofortified food crops basket (MBFC-Exp);   Other: Commercially available four food crops (MBFC-C)
    Sponsors:   Cornell University;   SNDT Women's University;   Arogyavaram Medical Centre
    Recruiting

  • Conditions:   Blindness;   Leber Congenital Amaurosis 10;   Vision Disorders;   Eye Diseases;   Eye Diseases, Hereditary;   Eye Disorders Congenital;   Retinal Disease;   Retinal Degeneration
    Intervention:   Drug: AGN-151587
    Sponsors:   Allergan;   Editas Medicine, Inc.
    Recruiting

  • Conditions:   Blindness;   Leber Congenital Amaurosis 10;   Vision Disorders;   Eye Diseases;   Eye Diseases, Hereditary;   Eye Disorders Congenital;   Retinal Disease;   Retinal Degeneration
    Intervention:  
    Sponsors:   Allergan;   Editas Medicine, Inc.
    Recruiting

  • Conditions:   Retinal Disease;   Age-Related Macular Degeneration;   Retinitis Pigmentosa;   Stargardt Disease;   Optic Neuropathy;   Nonarteritic Ischemic Optic Neuropathy;   Optic Atrophy;   Optic Nerve Disease;   Glaucoma;   Leber Hereditary Optic Neuropathy;   Blindness;   Vision Loss Night;   Vision Loss Partial;   Vision, Low;   Retinopathy;   Maculopathy;   Macular Degeneration;   Retina Atrophy
    Interventions:   Procedure: Arm 1;   Procedure: Arm 2;   Procedure: Arm 3
    Sponsor:   MD Stem Cells
    Recruiting

  • Conditions:   Overweight and Obesity;   Vitamin A Deficiency;   Dietary Modification;   Breastfeeding
    Interventions:   Behavioral: Intervention-Nutrition guidelines;   Behavioral: Nutrition guidelines
    Sponsors:   Universidad de Sonora;   Centro de Investigación en Alimentación y Desarrollo A.C.;   University of Wisconsin, Madison
    Recruiting

  • Conditions:   Rare Disorders;   Undiagnosed Disorders;   Disorders of Unknown Prevalence;   Cornelia De Lange Syndrome;   Prenatal Benign Hypophosphatasia;   Perinatal Lethal Hypophosphatasia;   Odontohypophosphatasia;   Adult Hypophosphatasia;   Childhood-onset Hypophosphatasia;   Infantile Hypophosphatasia;   Hypophosphatasia;   Kabuki Syndrome;   Bohring-Opitz Syndrome;   Narcolepsy Without Cataplexy;   Narcolepsy-cataplexy;   Hypersomnolence Disorder;   Idiopathic Hypersomnia Without Long Sleep Time;   Idiopathic Hypersomnia With Long Sleep Time;   Idiopathic Hypersomnia;   Kleine-Levin Syndrome;   Kawasaki Disease;   Leiomyosarcoma;   Leiomyosarcoma of the Corpus Uteri;   Leiomyosarcoma of the Cervix Uteri;   Leiomyosarcoma of Small Intestine;   Acquired Myasthenia Gravis;   Addison Disease;   Hyperacusis (Hyperacousis);   Juvenile Myasthenia Gravis;   Transient Neonatal Myasthenia Gravis;   Williams Syndrome;   Lyme Disease;   Myasthenia Gravis;   Marinesco Sjogren Syndrome(Marinesco-Sjogren Syndrome);   Isolated Klippel-Feil Syndrome;   Frasier Syndrome;   Denys-Drash Syndrome;   Beckwith-Wiedemann Syndrome;   Emanuel Syndrome;   Isolated Aniridia;   Beckwith-Wiedemann Syndrome Due to Paternal Uniparental Disomy of Chromosome 11;   Beckwith-Wiedemann Syndrome Due to Imprinting Defect of 11p15;   Beckwith-Wiedemann Syndrome Due to 11p15 Translocation/Inversion;   Beckwith-Wiedemann Syndrome Due to 11p15 Microduplication;   Beckwith-Wiedemann Syndrome Due to 11p15 Microdeletion;   Axenfeld-Rieger Syndrome;   Aniridia-intellectual Disability Syndrome;   Aniridia - Renal Agenesis - Psychomotor Retardation;   Aniridia - Ptosis - Intellectual Disability - Familial Obesity;   Aniridia - Cerebellar Ataxia - Intellectual Disability;   Aniridia - Absent Patella;   Aniridia;   Peters Anomaly - Cataract;   Peters Anomaly;   Potocki-Shaffer Syndrome;   Silver-Russell Syndrome Due to Maternal Uniparental Disomy of Chromosome 11;   Silver-Russell Syndrome Due to Imprinting Defect of 11p15;   Silver-Russell Syndrome Due to 11p15 Microduplication;   Syndromic Aniridia;   WAGR Syndrome;   Wolf-Hirschhorn Syndrome;   4p16.3 Microduplication Syndrome;   4p Deletion Syndrome, Non-Wolf-Hirschhorn Syndrome;   Autosomal Recessive Stickler Syndrome;   Stickler Syndrome Type 2;   Stickler Syndrome Type 1;   Stickler Syndrome;   Mucolipidosis Type 4;   X-linked Spinocerebellar Ataxia Type 4;   X-linked Spinocerebellar Ataxia Type 3;   X-linked Intellectual Disability - Ataxia - Apraxia;   X-linked Progressive Cerebellar Ataxia;   X-linked Non Progressive Cerebellar Ataxia;   X-linked Cerebellar Ataxia;   Vitamin B12 Deficiency Ataxia;   Toxic Exposure Ataxia;   Unclassified Autosomal Dominant Spinocerebellar Ataxia;   Thyroid Antibody Ataxia;   Sporadic Adult-onset Ataxia of Unknown Etiology;   Spinocerebellar Ataxia With Oculomotor Anomaly;   Spinocerebellar Ataxia With Epilepsy;   Spinocerebellar Ataxia With Axonal Neuropathy Type 2;   Spinocerebellar Ataxia Type 8;   Spinocerebellar Ataxia Type 7;   Spinocerebellar Ataxia Type 6;   Spinocerebellar Ataxia Type 5;   Spinocerebellar Ataxia Type 4;   Spinocerebellar Ataxia Type 37;   Spinocerebellar Ataxia Type 36;   Spinocerebellar Ataxia Type 35;   Spinocerebellar Ataxia Type 34;   Spinocerebellar Ataxia Type 32;   Spinocerebellar Ataxia Type 31;   Spinocerebellar Ataxia Type 30;   Spinocerebellar Ataxia Type 3;   Spinocerebellar Ataxia Type 29;   Spinocerebellar Ataxia Type 28;   Spinocerebellar Ataxia Type 27;   Spinocerebellar Ataxia Type 26;   Spinocerebellar Ataxia Type 25;   Spinocerebellar Ataxia Type 23;   Spinocerebellar Ataxia Type 22;   Spinocerebellar Ataxia Type 21;   Spinocerebellar Ataxia Type 20;   Spinocerebellar Ataxia Type 2;   Spinocerebellar Ataxia Type 19/22;   Spinocerebellar Ataxia Type 18;   Spinocerebellar Ataxia Type 17;   Spinocerebellar Ataxia Type 16;   Spinocerebellar Ataxia Type 15/16;   Spinocerebellar Ataxia Type 14;   Spinocerebellar Ataxia Type 13;   Spinocerebellar Ataxia Type 12;   Spinocerebellar Ataxia Type 11;   Spinocerebellar Ataxia Type 10;   Spinocerebellar Ataxia Type 1 With Axonal Neuropathy;   Spinocerebellar Ataxia Type 1;   Spinocerebellar Ataxia - Unknown;   Spinocerebellar Ataxia - Dysmorphism;   Non Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature;   Spectrin-associated Autosomal Recessive Cerebellar Ataxia;   Spasticity-ataxia-gait Anomalies Syndrome;   Spastic Ataxia With Congenital Miosis;   Spastic Ataxia - Corneal Dystrophy;   Spastic Ataxia;   Rare Hereditary Ataxia;   Rare Ataxia;   Recessive Mitochondrial Ataxia Syndrome;   Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature;   Posterior Column Ataxia - Retinitis Pigmentosa;   Post-Stroke Ataxia;   Post-Head Injury Ataxia;   Post Vaccination Ataxia;   Polyneuropathy - Hearing Loss - Ataxia - Retinitis Pigmentosa - Cataract;   Muscular Atrophy - Ataxia - Retinitis Pigmentosa - Diabetes Mellitus;   Non-progressive Cerebellar Ataxia With Intellectual Disability;   Non-hereditary Degenerative Ataxia;   Paroxysmal Dystonic Choreathetosis With Episodic Ataxia and Spasticity;   Olivopontocerebellar Atrophy - Deafness;   NARP Syndrome;   Myoclonus - Cerebellar Ataxia - Deafness;   Multiple System Atrophy, Parkinsonian Type;   Multiple System Atrophy, Cerebellar Type;   Multiple System Atrophy;   Maternally-inherited Leigh Syndrome;   Machado-Joseph Disease Type 3;   Machado-Joseph Disease Type 2;   Machado-Joseph Disease Type 1;   Lethal Ataxia With Deafness and Optic Atrophy;   Leigh Syndrome;   Leukoencephalopathy With Mild Cerebellar Ataxia and White Matter Edema;   Leukoencephalopathy - Ataxia - Hypodontia - Hypomyelination;   Leigh Syndrome With Nephrotic Syndrome;   Leigh Syndrome With Leukodystrophy;   Leigh Syndrome With Cardiomyopathy;   Late-onset Ataxia With Dementia;   Intellectual Disability-hyperkinetic Movement-truncal Ataxia Syndrome;   Infection or Post Infection Ataxia;   Infantile-onset Autosomal Recessive Nonprogressive Cerebellar Ataxia;   Infantile Onset Spinocerebellar Ataxia;   GAD Ataxia;   Hereditary Episodic Ataxia;   Gliadin/Gluten Ataxia;   Friedreich Ataxia;   Fragile X-associated Tremor/Ataxia Syndrome;   Familial Paroxysmal Ataxia;   Exposure to Medications Ataxia;   Episodic Ataxia With Slurred Speech;   Episodic Ataxia Unknown Type;   Episodic Ataxia Type 7;   Episodic Ataxia Type 6;   Episodic Ataxia Type 5;   Episodic Ataxia Type 4;   Episodic Ataxia Type 3;   Episodic Ataxia Type 1;   Epilepsy and/or Ataxia With Myoclonus as Major Feature;   Early-onset Spastic Ataxia-neuropathy Syndrome;   Early-onset Progressive Neurodegeneration - Blindness - Ataxia - Spasticity;   Early-onset Cerebellar Ataxia With Retained Tendon Reflexes;   Early-onset Ataxia With Dementia;   Childhood-onset Autosomal Recessive Slowly Progressive Spinocerebellar Ataxia;   Dilated Cardiomyopathy With Ataxia;   Cataract - Ataxia - Deafness;   Cerebellar Ataxia, Cayman Type;   Cerebellar Ataxia With Peripheral Neuropathy;   Cerebellar Ataxia - Hypogonadism;   Cerebellar Ataxia - Ectodermal Dysplasia;   Cerebellar Ataxia - Areflexia - Pes Cavus - Optic Atrophy - Sensorineural Hearing Loss;   Brain Tumor Ataxia;   Brachydactyly - Nystagmus - Cerebellar Ataxia;   Benign Paroxysmal Tonic Upgaze of Childhood With Ataxia;   Autosomal Recessive Syndromic Cerebellar Ataxia;   Autosomal Recessive Spastic Ataxia With Leukoencephalopathy;   Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay;   Autosomal Recessive Spastic Ataxia - Optic Atrophy - Dysarthria;   Autosomal Recessive Spastic Ataxia;   Autosomal Recessive Metabolic Cerebellar Ataxia;   Autosomal Dominant Spinocerebellar Ataxia Due to Repeat Expansions That do Not Encode Polyglutamine;   Autosomal Recessive Ataxia, Beauce Type;   Autosomal Recessive Ataxia Due to Ubiquinone Deficiency;   Autosomal Recessive Ataxia Due to PEX10 Deficiency;   Autosomal Recessive Degenerative and Progressive Cerebellar Ataxia;   Autosomal Recessive Congenital Cerebellar Ataxia Due to MGLUR1 Deficiency;   Autosomal Recessive Congenital Cerebellar Ataxia Due to GRID2 Deficiency;   Autosomal Recessive Congenital Cerebellar Ataxia;   Autosomal Recessive Cerebellar Ataxia-pyramidal Signs-nystagmus-oculomotor Apraxia Syndrome;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to WWOX Deficiency;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to TUD Deficiency;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to KIAA0226 Deficiency;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome;   Autosomal Recessive Cerebellar Ataxia With Late-onset Spasticity;   Autosomal Recessive Cerebellar Ataxia Due to STUB1 Deficiency;   Autosomal Recessive Cerebellar Ataxia Due to a DNA Repair Defect;   Autosomal Recessive Cerebellar Ataxia - Saccadic Intrusion;   Autosomal Recessive Cerebellar Ataxia - Psychomotor Retardation;   Autosomal Recessive Cerebellar Ataxia - Blindness - Deafness;   Autosomal Recessive Cerebellar Ataxia;   Autosomal Dominant Spinocerebellar Ataxia Due to a Polyglutamine Anomaly;   Autosomal Dominant Spinocerebellar Ataxia Due to a Point Mutation;   Autosomal Dominant Spinocerebellar Ataxia Due to a Channelopathy;   Autosomal Dominant Spastic Ataxia Type 1;   Autosomal Dominant Spastic Ataxia;   Autosomal Dominant Optic Atrophy;   Ataxia-telangiectasia Variant;   Ataxia-telangiectasia;   Autosomal Dominant Cerebellar Ataxia, Deafness and Narcolepsy;   Autosomal Dominant Cerebellar Ataxia Type 4;   Autosomal Dominant Cerebellar Ataxia Type 3;   Autosomal Dominant Cerebellar Ataxia Type 2;   Autosomal Dominant Cerebellar Ataxia Type 1;   Autosomal Dominant Cerebellar Ataxia;   Ataxia-telangiectasia-like Disorder;   Ataxia-intellectual Disability-oculomotor Apraxia-cerebellar Cysts Syndrome;   Ataxia-deafness-intellectual Disability Syndrome;   Ataxia With Vitamin E Deficiency;   Ataxia With Dementia;   Ataxia Neuropathy Spectrum;   Ataxia - Tapetoretinal Degeneration;   Ataxia - Photosensitivity - Short Stature;   Ataxia - Pancytopenia;   Ataxia - Oculomotor Apraxia Type 1;   Ataxia - Hypogonadism - Choroidal Dystrophy;   Ataxia - Other;   Ataxia - Genetic Diagnosis - Unknown;   Acquired Ataxia;   Adult-onset Autosomal Recessive Cerebellar Ataxia;   Alcohol Related Ataxia;   Multiple Endocrine Neoplasia;   Multiple Endocrine Neoplasia Type II;   Multiple Endocrine Neoplasia Type 1;   Multiple Endocrine Neoplasia Type 2;   Multiple Endocrine Neoplasia, Type IV;   Multiple Endocrine Neoplasia, Type 3;   Multiple Endocrine Neoplasia (MEN) Syndrome;   Multiple Endocrine Neoplasia Type 2B;   Multiple Endocrine Neoplasia Type 2A;   Atypical Hemolytic Uremic Syndrome;   Atypical HUS;   Wiedemann-Steiner Syndrome;   Breast Implant-Associated Anaplastic Large Cell Lymphoma;   Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA);   Hemophagocytic Lymphohistiocytosis;   Behcet's Disease;   Alagille Syndrome;   Inclusion Body Myopathy With Early-onset Paget Disease and Frontotemporal Dementia (IBMPFD);   Lowe Syndrome;   Pitt Hopkins Syndrome;   1p36 Deletion Syndrome;   Jansen Type Metaphyseal Chondrodysplasia;   Cockayne Syndrome;   Chronic Recurrent Multifocal Osteomyelitis;   CRMO;   Malan Syndrome;   Hereditary Sensory and Autonomic Neuropathy Type Ie
    Intervention:  
    Sponsors:   Sanford Health;   National Ataxia Foundation;   International WAGR Syndrome Association;   4p- Support Group;   ML4 Foundation;   Cornelia de Lange Syndrome Foundation;   Stickler Involved People;   Kawasaki Disease Foundation;   Klippel-Feil Syndrome Alliance;   Klippel-Feil Syndrome Freedom;   Hyperacusis Research Limited;   Hypersomnia Foundation;   Kabuki Syndrome Network;   Kleine-Levin Syndrome Foundation;   Leiomyosarcoma Direct Research Foundation;   Marinesco-Sjogren Syndrome Support Group - NORD;   Mucolipidosis Type IV (ML4) Foundation;   People with Narcolepsy 4 People with Narcolepsy (PWN4PWN);   Soft Bones Incorporated;   American Multiple Endocrine Neoplasia Support;   Atypical Hemolytic Uremic Syndrome Foundation;   All Things Kabuki;   Wiedemann-Steiner Syndrome Foundation;   Breast Implant Victim Advocates;   PROS Foundation;   American Behcet's Disease Association
    Recruiting

  • Conditions:   Leber Congenital Amaurosis 10;   Blindness;   Leber Congenital Amaurosis;   Vision Disorders;   Sensation Disorders;   Neurologic Manifestations;   Eye Diseases;   Eye Diseases, Hereditary;   Eye Disorders Congenital;   Retinal Disease
    Interventions:   Drug: QR-110;   Other: Sham
    Sponsor:   ProQR Therapeutics
    Recruiting

  • Conditions:   Leber Congenital Amaurosis 10;   Blindness;   Leber Congenital Amaurosis;   Vision Disorders;   Sensation Disorders;   Neurologic Manifestations;   Eye Diseases;   Eye Diseases, Hereditary;   Eye Disorders Congenital;   Retinal Disease
    Intervention:   Drug: QR-110
    Sponsor:   ProQR Therapeutics
    Recruiting

  • Conditions:   Increased Lordosis/Scoliosis;   Hyporeflexia;   Duchenne Muscular Dystrophy;   Red-Green Color Blindness;   Lordosis;   Scoliosis;   Muscular Atrophy;   Muscular Weakness
    Intervention:  
    Sponsor:   Centogene AG Rostock
    Recruiting

  • Condition:   Advanced Dry Macular Degeneration
    Intervention:   Device: Alpha MSH assay
    Sponsor:   Duke University
    Recruiting

  • Conditions:   Preeclampsia;   Vitamin A Deficiency;   Vitamin E Deficiency
    Interventions:   Drug: Vitamin A;   Drug: Vitamin E
    Sponsor:   Second Affiliated Hospital, School of Medicine, Zhejiang University
    Recruiting

  • Condition:   Post-Traumatic Stress Disorder
    Intervention:  
    Sponsor:   University Hospital, Lille
    Recruiting

  • Condition:   Schizophrenia
    Intervention:  
    Sponsor:   University Hospital, Lille
    Recruiting

  • Conditions:   ACHROMATOPSIA 7;   Achromatopsia
    Intervention:   Drug: PBA
    Sponsor:   Columbia University
    Not yet recruiting

  • Conditions:   Leber Congenital Amaurosis (LCA);   Eye Diseases;   Eye Diseases, Hereditary;   Retinal Diseases
    Intervention:   Biological: AAV OPTIRPE65
    Sponsors:   MeiraGTx UK II Ltd;   Syne Qua Non Limited
    Recruiting

  • Conditions:   Vitamin A Deficiency;   Vitamin D Deficiency;   Vitamin E Deficiency;   Very Low Birth Weight Infants;   Bronchopulmonary Dysplasia;   Anemia;   Sepsis
    Interventions:   Drug: High dose of fat-Soluble Vitamin;   Drug: Conventional dose of fat-Soluble Vitamin
    Sponsors:   First Affiliated Hospital Xi'an Jiaotong University;   Xi’an Gaoxin Hospital
    Recruiting

  • Condition:   Limbal Stem-cell Deficiency
    Intervention:  
    Sponsors:   Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA;   Citospin;   Red de Terapia Celular;   University of Valladolid
    Not yet recruiting

  • Condition:   Hemianopsia
    Intervention:   Device: tACS (transcranial Alternate Current Stimulation)
    Sponsor:   Assistance Publique - Hôpitaux de Paris
    Not yet recruiting

  • Conditions:   Visual Fields Hemianopsia;   Stroke, Ischemic;   Stroke Hemorrhagic
    Interventions:   Device: High frequency repetitive transcranial magnetic stimulation (rTMS);   Device: Sham stimulation
    Sponsor:   Ain Shams University
    Recruiting

  • Conditions:   Retinitis Pigmentosa;   Cone Dystrophy;   Usher Syndromes;   Retina; Dystrophy
    Interventions:   Diagnostic Test: Retina Analysis-mosaic;   Diagnostic Test: Autofluorescence;   Diagnostic Test: OCT- 1 micra;   Procedure: Genotype analysis
    Sponsors:   MejoraVisionMD;   Maisonneuve-Rosemont Hospital;   Retina and Genomics Institute
    Recruiting

  • Conditions:   Diabetes Mellitus, Type 1;   Monogenic Diabetes;   Neonatal Diabetes;   Maturity-onset Diabetes in the Young (MODY);   Wolfram Syndrome;   Wolcott-Rallison Syndrome;   Mitochondrial Diabetes
    Intervention:  
    Sponsor:   Constantin Polychronakos
    Not yet recruiting

  • Condition:   Wolfram Syndrome
    Intervention:  
    Sponsor:   Washington University School of Medicine
    Recruiting

  • Condition:   Usher Syndrome, Type 1B
    Intervention:  
    Sponsor:   Fondazione Telethon
    Recruiting

  • Conditions:   Retinitis Pigmentosa;   Usher Syndrome Type 2;   Deaf Blind;   Retinal Disease;   Eye Diseases;   Eye Diseases, Hereditary;   Eye Disorders Congenital;   Vision Disorders
    Interventions:   Drug: QR-421a;   Other: Sham-procedure
    Sponsor:   ProQR Therapeutics
    Recruiting

  • Condition:   Wolfram Syndrome
    Interventions:   Drug: Sodium Valproate 200Mg E/C Tablet;   Drug: Sodium Valproate matched placebo
    Sponsor:   University of Birmingham
    Recruiting

  • Conditions:   Stroke;   CVA (Cerebrovascular Accident);   CVA; Sequelae;   Stroke, Ischemic;   Stroke Hemorrhagic;   Hemianopia;   Hemiplegia;   Hemiparesis;   Aphasia;   Cerebral Infarction;   Intracerebral Hemorrhage;   Anxiety;   Depression;   Dysphagia;   Dysarthria;   Hemispatial Neglect;   Mild Cognitive Impairment
    Intervention:  
    Sponsor:   Aneurin Bevan University Health Board
    Recruiting

  • Conditions:   Ischemic Optic Neuropathy;   Branch Retinal Artery Occlusion;   Hemianopia;   Leber Hereditary Optic Neuropathy;   Acute Zonal Occult Outer Retinopathy
    Intervention:   Device: LSFG-NAVI
    Sponsor:   Randy Kardon
    Recruiting

  • Conditions:   Wolfram Syndrome;   Diabetes Mellitus;   Optic Nerve Atrophy;   Deafness;   Diabetes Insipidus;   Ataxia
    Intervention:  
    Sponsors:   Washington University School of Medicine;   American Diabetes Association;   National Institutes of Health (NIH)
    Recruiting

  • Conditions:   Wolfram Syndrome;   Diabetes Mellitus;   Optic Nerve Atrophy;   Ataxia
    Intervention:   Drug: dantrolene sodium
    Sponsors:   Washington University School of Medicine;   National Institutes of Health (NIH)
    Recruiting

  • Conditions:   Usher Syndrome;   Retinitis Pigmentosa
    Intervention:   Genetic: SAR421869
    Sponsor:   Sanofi
    Recruiting

  • Conditions:   Diabetic Macular Edema;   Diabetic Retinopathy
    Interventions:   Drug: DME lactose pill;   Drug: DME levosulpiride;   Drug: DR lactose pill;   Drug: DR levosulpiride;   Drug: DR vitrectomy lactose pill;   Drug: DR vitrectomy levosulpiride;   Drug: DME plus ranibizumab lactose pill;   Drug: DME plus ranibizumab levosulpiride
    Sponsors:   Carmen Clapp;   Instituto Mexicano de Oftalmologia;   Universidad Autonoma de Queretaro;   General Hospital Nuremberg & Paracelsus Medical University Nuremberg
    Recruiting

  • Conditions:   Wet Age-related Macular Degeneration;   Neovascular Age-related Macular Degeneration
    Intervention:   Biological: ADVM-022
    Sponsor:   Adverum Biotechnologies, Inc.
    Recruiting